Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1963859137;59138;59139 chr2:178593296;178593295;178593294chr2:179458023;179458022;179458021
N2AB1799754214;54215;54216 chr2:178593296;178593295;178593294chr2:179458023;179458022;179458021
N2A1707051433;51434;51435 chr2:178593296;178593295;178593294chr2:179458023;179458022;179458021
N2B1057331942;31943;31944 chr2:178593296;178593295;178593294chr2:179458023;179458022;179458021
Novex-11069832317;32318;32319 chr2:178593296;178593295;178593294chr2:179458023;179458022;179458021
Novex-21076532518;32519;32520 chr2:178593296;178593295;178593294chr2:179458023;179458022;179458021
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Fn3-30
  • Domain position: 60
  • Structural Position: 90
  • Q(SASA): 0.4733
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/I rs1257692385 0.765 0.966 N 0.636 0.476 0.675970969783 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 3.27E-05 None 0 0 0
K/I rs1257692385 0.765 0.966 N 0.636 0.476 0.675970969783 gnomAD-4.0.0 1.59197E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.43312E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.3411 ambiguous 0.3983 ambiguous -0.763 Destabilizing 0.688 D 0.505 neutral None None None None N
K/C 0.629 likely_pathogenic 0.6951 pathogenic -0.705 Destabilizing 0.998 D 0.657 neutral None None None None N
K/D 0.6194 likely_pathogenic 0.6757 pathogenic 0.067 Stabilizing 0.728 D 0.519 neutral None None None None N
K/E 0.2106 likely_benign 0.2449 benign 0.241 Stabilizing 0.022 N 0.298 neutral N 0.405886802 None None N
K/F 0.8308 likely_pathogenic 0.865 pathogenic -0.317 Destabilizing 0.991 D 0.637 neutral None None None None N
K/G 0.5472 ambiguous 0.5979 pathogenic -1.146 Destabilizing 0.842 D 0.558 neutral None None None None N
K/H 0.2884 likely_benign 0.3287 benign -1.089 Destabilizing 0.974 D 0.595 neutral None None None None N
K/I 0.3979 ambiguous 0.4506 ambiguous 0.257 Stabilizing 0.966 D 0.636 neutral N 0.494892653 None None N
K/L 0.4606 ambiguous 0.5052 ambiguous 0.257 Stabilizing 0.842 D 0.563 neutral None None None None N
K/M 0.2759 likely_benign 0.3093 benign -0.1 Destabilizing 0.974 D 0.593 neutral None None None None N
K/N 0.4504 ambiguous 0.519 ambiguous -0.536 Destabilizing 0.801 D 0.467 neutral N 0.477325613 None None N
K/P 0.9433 likely_pathogenic 0.9421 pathogenic -0.055 Destabilizing 0.974 D 0.595 neutral None None None None N
K/Q 0.1174 likely_benign 0.1387 benign -0.442 Destabilizing 0.051 N 0.298 neutral N 0.423376484 None None N
K/R 0.0773 likely_benign 0.0779 benign -0.258 Destabilizing 0.669 D 0.517 neutral N 0.421432257 None None N
K/S 0.3601 ambiguous 0.4254 ambiguous -1.242 Destabilizing 0.842 D 0.503 neutral None None None None N
K/T 0.1451 likely_benign 0.1693 benign -0.839 Destabilizing 0.801 D 0.515 neutral N 0.426760719 None None N
K/V 0.3072 likely_benign 0.3397 benign -0.055 Destabilizing 0.915 D 0.592 neutral None None None None N
K/W 0.8438 likely_pathogenic 0.8661 pathogenic -0.208 Destabilizing 0.998 D 0.685 prob.neutral None None None None N
K/Y 0.6241 likely_pathogenic 0.6785 pathogenic 0.075 Stabilizing 0.991 D 0.633 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.